These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23874957)

  • 21. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
    Akhiani AA; Stensson A; Schön K; Lycke NY
    J Immunol; 2005 Jun; 174(12):8144-53. PubMed ID: 15944323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Bacillus subtilis Spores Elicit Th1/Th17-Polarized Immune Response in a Murine Model of Helicobacter pylori Vaccination.
    Stasiłojć M; Hinc K; Peszyńska-Sularz G; Obuchowski M; Iwanicki A
    Mol Biotechnol; 2015 Aug; 57(8):685-91. PubMed ID: 25779639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases.
    Rocha GA; de Melo FF; Cabral MMDA; de Brito BB; da Silva FAF; Queiroz DMM
    Helicobacter; 2020 Feb; 25(1):e12667. PubMed ID: 31702083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori-infected macrophages induce Th17 cell differentiation.
    Zhuang Y; Shi Y; Liu XF; Zhang JY; Liu T; Fan X; Luo J; Wu C; Yu S; Chen L; Luo P; Guo G; Liu Z; Tang B; Mao XH; Guo Y; Zou QM
    Immunobiology; 2011; 216(1-2):200-7. PubMed ID: 21112468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
    Velin D; Favre L; Bernasconi E; Bachmann D; Pythoud C; Saiji E; Bouzourene H; Michetti P
    Gastroenterology; 2009 Jun; 136(7):2237-2246.e1. PubMed ID: 19272385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
    Taylor JM; Ziman ME; Huff JL; Moroski NM; Vajdy M; Solnick JV
    Vaccine; 2006 Jun; 24(23):4987-94. PubMed ID: 16621176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.
    Blanchard TG; Czinn SJ; Redline RW; Sigmund N; Harriman G; Nedrud JG
    Cell Immunol; 1999 Jan; 191(1):74-80. PubMed ID: 9918689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of IFN-gamma and IL-4 in gastric mucosa inflammation associated with Helicobacter heilmannii type 1 infection.
    Cinque SM; Rocha GA; Correa-Oliveira R; Soares TF; Moura SB; Rocha AM; Nogueira AM; Cabral MM; Vieira LQ; Martins-Filho OA; Queiroz DM
    Braz J Med Biol Res; 2006 Feb; 39(2):253-61. PubMed ID: 16470313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
    Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
    World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.
    Sommer F; Wilken H; Faller G; Lohoff M
    Infect Immun; 2004 Feb; 72(2):1029-35. PubMed ID: 14742550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori.
    Gobert AP; Verriere T; Asim M; Barry DP; Piazuelo MB; de Sablet T; Delgado AG; Bravo LE; Correa P; Peek RM; Chaturvedi R; Wilson KT
    J Immunol; 2014 Sep; 193(6):3013-22. PubMed ID: 25108023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of a Th17 cell response by Helicobacter pylori Urease subunit B.
    Zhang JY; Liu T; Guo H; Liu XF; Zhuang Y; Yu S; Chen L; Wu C; Zhao Z; Tang B; Luo P; Mao XH; Guo G; Shi Y; Zou QM
    Immunobiology; 2011 Jul; 216(7):803-10. PubMed ID: 21269729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.
    Kao JY; Zhang M; Miller MJ; Mills JC; Wang B; Liu M; Eaton KA; Zou W; Berndt BE; Cole TS; Takeuchi T; Owyang SY; Luther J
    Gastroenterology; 2010 Mar; 138(3):1046-54. PubMed ID: 19931266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.
    Horvath DJ; Radin JN; Cho SH; Washington MK; Algood HM
    PLoS One; 2013; 8(3):e60363. PubMed ID: 23533678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of circulating integrin α4β7
    Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
    Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids.
    Chen J; Lin L; Li N; She F
    Microbiol Immunol; 2012 Feb; 56(2):85-92. PubMed ID: 22150716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
    Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
    PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses.
    Fox JG; Sheppard BJ; Dangler CA; Whary MT; Ihrig M; Wang TC
    Cancer Res; 2002 Feb; 62(3):696-702. PubMed ID: 11830522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.